NFL BIOSCIENCES: EFFICACY VALIDATED THROUGH UPDATED ANALYSES FROM CESTO II FOR SMOKING CESSATION. SIGNIFICANT REDUCTION IN CRAVING. STRONG COMMERCIAL POTENTIAL CONFIRMED.
08 Oct 2024 08:00 CEST
Issuer
NFL BIOSCIENCES S.A.
See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo
16165_1289023_NFLBiosciences_CP_ResultatscomplementairesCESTOII_EN_Final.pdf
Source
NFL BIOSCIENCES
Provider
Les Echos
Company Name
NFL BIOSCIENCES S.A.
ISIN
FR0014003XT0
Symbol
ALNFL
Market
Euronext Growth